Conference Coverage

Targeting inactivity, mood, and cognition could be key to reducing OA mortality


 

REPORTING FROM OARSI 2018


The analysis used data on more than 8,000 individuals participating in the NorStOP (North Staffordshire Osteoarthritis Project). This is a large, population-based, prospective cohort initiated in 2002 that includes adults aged 50 years or older who are registered at any of six general practices.

At baseline, the mean age of participants was 65 years, 51% were female, and just under 30% had OA. During 10 years of follow-up, 1,188 (14.7%) participants died.


Osteoarthritis was significantly associated with mortality in both unadjusted and adjusted analyses.

“For the average person presenting to general practice in North Staffordshire, there’s a 39.4% increased risk of mortality if they have osteoarthritis compared to if they don’t,” Mr. Parmar said.

Pages

Recommended Reading

Pediatric psoriasis linked to multiple psychiatric comorbidities
MDedge Rheumatology
Screen opioid users for depression, study recommends
MDedge Rheumatology
New report highlights gaps in knowledge on marijuana use
MDedge Rheumatology
Brodalumab approved for psoriasis with REMS required
MDedge Rheumatology
SPECT reveals perfusion problems in antiphospholipid syndrome
MDedge Rheumatology
Depressed OA patients get far-reaching benefits from Internet-delivered CBT
MDedge Rheumatology
Psoriasis patients face higher risk of alcohol-related death – but lower suicide risk
MDedge Rheumatology
Guselkumab tops adalimumab for psychiatric comorbidities in psoriasis
MDedge Rheumatology
Use of opioids, SSRIs linked to increased fracture risk in RA
MDedge Rheumatology
RA associated with higher risk of psychiatric disorders
MDedge Rheumatology